CSat Investment Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,813
Closed -$138K 578
2020
Q3
$138K Buy
1,813
+160
+10% +$12.2K 0.01% 354
2020
Q2
$204K Buy
1,653
+1,236
+296% +$153K 0.02% 306
2020
Q1
$35K Buy
417
+52
+14% +$4.37K 0.01% 608
2019
Q4
$31K Buy
365
+66
+22% +$5.61K 0.01% 681
2019
Q3
$20K Buy
299
+24
+9% +$1.61K 0.01% 706
2019
Q2
$24K Buy
+275
New +$24K 0.01% 662